Intersection of Black race and carbohydrate antigen 19‐9 nonproduction underpins worse pathologic response to neoadjuvant therapy in pancreatic cancer
Cancer · 2025
DOI: 10.1002/cncr.70130 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer, 2025. Verfasst von Mary P Martos und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Surgical Oncology, Department of Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA. Hauptthemen laut MEDLINE: Black or African American, CA-19-9 Antigen, Carcinoma, Pancreatic Ductal, Pancreatic Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NIH HHS.
Abstract (Originalsprache)
Background
Black patients with pancreatic ductal adenocarcinoma (PDAC) are less likely to have a major pathologic response (MPR) after neoadjuvant chemotherapy (NAC). Data suggest lower baseline carbohydrate antigen 19‐9 (CA 19‐9) among Black patients. Whether CA 19‐9 nonproduction contributes to racial differences in NAC response was evaluated, and the biological mechanisms underlying the reduced response in CA 19‐9 nonproducers (CAnonprod) were investigated.
Methods
Black and White patients with PDAC who received ≥2 NAC cycles and pancreatectomy at seven centers were reviewed. Patients were categorized as CA 19‐9 producers (CAprod; CA 19‐9 > 5 U/mL) or CAnonprod (CA 19‐9 ≤ 5 U/mL). Univariable and multivariable models assessed CAnonprod rates by race and the association of CAnonprod with MPR. The Pancreatic Cancer Action Network’s SPARK platform was queried for genomic data. Differentially mutated genes were identified by Fisher exact test; differentially expressed gene analysis used an absolute fold change of ≥2 and an adjusted p value of
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Surgical Oncology, Department of Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA.
- Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida, USA.
- Pancreatic Cancer Action Network Manhattan Beach, Los Angeles, California, USA.
- Division of Surgical Oncology, Department of Surgery, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
- Division of Surgical Oncology, Northwestern University Lurie Comprehensive Cancer Center, Chicago, Illinois, USA.
- Department of Surgery, Washington University in St. Louis, St. Louis, Missouri, USA.
ORCID-Profile: Mary P Martos, Kawther Abdilleh, Shishir K Maithel
Förderung
- NCI NIH HHS
- NIH HHS
Zitieren
APA
Martos, M. P., Dickey, E. M., Abdilleh, K., Ahmad, S. A., Maithel, S. K., Leigh-Matijakovich, N., Kim, H. J., Abbott, D. E., Zafar, S. N., Kooby, D. A., Parikh, A. A., Hosein, P. J., Merchant, N. B., Datta, J., & Hester, C. A. (2025). Intersection of Black race and carbohydrate antigen 19‐9 nonproduction underpins worse pathologic response to neoadjuvant therapy in pancreatic cancer. Cancer. https://doi.org/10.1002/cncr.70130
Vancouver
Martos MP, Dickey EM, Abdilleh K, Ahmad SA, Maithel SK, Leigh-Matijakovich N, et al. Intersection of Black race and carbohydrate antigen 19‐9 nonproduction underpins worse pathologic response to neoadjuvant therapy in pancreatic cancer. Cancer. 2025. doi:10.1002/cncr.70130
BibTeX
@article{Martos2025,
author = {Martos, Mary P and Dickey, Erin M and Abdilleh, Kawther and Ahmad, Syed A and Maithel, Shishir K and Leigh-Matijakovich, Natasha and Kim, Hong Jin and Abbott, Daniel E and Zafar, Syed Nabeel and Kooby, David A and Parikh, Alexander A and Hosein, Peter J and Merchant, Nipun B and Datta, Jashodeep and Hester, Caitlin A},
title = {Intersection of Black race and carbohydrate antigen 19‐9 nonproduction underpins worse pathologic response to neoadjuvant therapy in pancreatic cancer},
journal = {Cancer},
year = {2025},
doi = {10.1002/cncr.70130}
}
EUVIMED